潍坊医学院学报
濰坊醫學院學報
유방의학원학보
JOURNAL OF WEIFANG MEDICAL COLLEGE
2015年
3期
186-188
,共3页
肺肿瘤,晚期%血小板计数%预后
肺腫瘤,晚期%血小闆計數%預後
폐종류,만기%혈소판계수%예후
Platelet count%Advanced lung cancer%Prognosis
目的:探讨血小板计数水平与晚期非小细胞肺癌( NSCLC )预后之间的关系。方法回顾性分析68例晚期NSCLC患者初治前的外周血小板计数水平,将其按血小板计数的高低分为:血小板升高组A (+)、血小板正常组A(-),随访并分析血小板计数水平的高低与患者性别、年龄、病理类型及临床分期的关系,并比较血小板计数水平对患者生存期的影响。采用Kaplan-Meier法进行生存分析,采用Log-Rank检验比较生存期的差异,用COX比例风险模型进行血小板升高对肺癌患者预后的影响。结果血小板计数升高与年龄、性别及肺癌的病理类型无关(P>0.05);而与临床分期有关(P<0.05)。结论肺癌患者血小板计数水平是影响晚期肺癌患者预后的诸多因素之一。
目的:探討血小闆計數水平與晚期非小細胞肺癌( NSCLC )預後之間的關繫。方法迴顧性分析68例晚期NSCLC患者初治前的外週血小闆計數水平,將其按血小闆計數的高低分為:血小闆升高組A (+)、血小闆正常組A(-),隨訪併分析血小闆計數水平的高低與患者性彆、年齡、病理類型及臨床分期的關繫,併比較血小闆計數水平對患者生存期的影響。採用Kaplan-Meier法進行生存分析,採用Log-Rank檢驗比較生存期的差異,用COX比例風險模型進行血小闆升高對肺癌患者預後的影響。結果血小闆計數升高與年齡、性彆及肺癌的病理類型無關(P>0.05);而與臨床分期有關(P<0.05)。結論肺癌患者血小闆計數水平是影響晚期肺癌患者預後的諸多因素之一。
목적:탐토혈소판계수수평여만기비소세포폐암( NSCLC )예후지간적관계。방법회고성분석68례만기NSCLC환자초치전적외주혈소판계수수평,장기안혈소판계수적고저분위:혈소판승고조A (+)、혈소판정상조A(-),수방병분석혈소판계수수평적고저여환자성별、년령、병리류형급림상분기적관계,병비교혈소판계수수평대환자생존기적영향。채용Kaplan-Meier법진행생존분석,채용Log-Rank검험비교생존기적차이,용COX비례풍험모형진행혈소판승고대폐암환자예후적영향。결과혈소판계수승고여년령、성별급폐암적병리류형무관(P>0.05);이여림상분기유관(P<0.05)。결론폐암환자혈소판계수수평시영향만기폐암환자예후적제다인소지일。
Objective To explore the relationship between the level of platelet count and prognosis of ad-vanced non-small cell lung cancer.Methods Retrospective analysis of the level of peripheral blood platelet count of 68 cases of patients with advanced non-small cell lung cancer before the first treated,follow-up and analysis of the platelet count's influence on the prognosis of lung cancer were made.Kaplan Meier-method was adopted to improve the survival a-nalysis,the Log-Rank test was used to compare the difference between the survival and increased platelet,COX propor-tional hazards models was used to evaluate the effect of hing peripheral blood platelet on the prognosis of patients with lung cancer.Results Platelet count had nothing to do with age,sex and pathological types of lung cancer,but was asso-ciated with clinical stage( P<0.05) .Conclusion The level of platelet count in patients with lung cancer is one of the many factors that affect the prognosis of patients with advanced lung cancer.Continuous dynamic observation on platelet count in patients with lung cancer contributes to the judjement of clinical condition and prognosis judgement.